YU-CHUNG CHUANGChueng Y.-C.CHUN-TA HUANG2020-12-292020-12-2920140090-3493https://www.scopus.com/inward/record.uri?eid=2-s2.0-84913543322&doi=10.1097%2fCCM.0000000000000489&partnerID=40&md5=f2401e7ac2e1e8b23461bd53b3d62a78https://scholars.lib.ntu.edu.tw/handle/123456789/535174[SDGs]SDG3rapamycin; steroid; glucocorticoid; immunosuppressive agent; prednisolone; rapamycin; adjuvant therapy; disease severity; drug efficacy; human; influenza A (H1N1); intensive care unit; Letter; mortality; outcome assessment; oxygenation; pneumonia; prospective study; protocol compliance; treatment outcome; ventilator; female; Influenza virus A H1N1; Influenza, Human; male; Pneumonia, Viral; Respiratory Insufficiency; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Pneumonia, Viral; Prednisolone; Respiratory Insufficiency; Sirolimusletter10.1097/CCM.000000000000048925226152